Ameritas Investment Partners’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,995
| Closed | -$2.43K | – | 3249 |
|
|
2025
Q1 | $2.43K | Hold |
1,995
| – | – | ﹤0.01% | 3064 |
|
|
2024
Q4 | $2.57K | Hold |
1,995
| – | – | ﹤0.01% | 3092 |
|
|
2024
Q3 | $5.49K | Hold |
1,995
| – | – | ﹤0.01% | 3027 |
|
|
2024
Q2 | $4.51K | Buy |
+1,995
| New | +$4.51K | ﹤0.01% | 3041 |
|
|
2021
Q2 | – | Sell |
-2,845
| Closed | -$6K | – | 3127 |
|
|
2021
Q1 | $6K | Hold |
2,845
| – | – | ﹤0.01% | 2977 |
|
|
2020
Q4 | $6K | Hold |
2,845
| – | – | ﹤0.01% | 2937 |
|
|
2020
Q3 | $8K | Hold |
2,845
| – | – | ﹤0.01% | 2806 |
|
|
2020
Q2 | $9K | Hold |
2,845
| – | – | ﹤0.01% | 2770 |
|
|
2020
Q1 | $6K | Hold |
2,845
| – | – | ﹤0.01% | 2750 |
|
|
2019
Q4 | $8K | Hold |
2,845
| – | – | ﹤0.01% | 2803 |
|
|
2019
Q3 | $10K | Hold |
2,845
| – | – | ﹤0.01% | 2747 |
|
|
2019
Q2 | $12K | Buy |
+2,845
| New | +$12K | ﹤0.01% | 2721 |
|